Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Courtney

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2018
IL-21 Selectively Protects CD62L<sup>+</sup> NKT Cells and Enhances Their Effector Functions for Adoptive ImmunotherapyHo Ngai, Gengwen Tian, Amy N Courtney, et al.
The Journal of Clinical Investigation|May 9, 2012
IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activityDaofeng Liu, Liping Song, Jie Wei, et al.
Blood|July 23, 2014
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapyAndras Heczey, Daofeng Liu, Gengwen Tian, et al.
The Journal of Clinical Investigation|May 17, 2016
CD62L+ NKT cells have prolonged persistence and antitumor activity in vivoGengwen Tian, Amy N Courtney, Bipulendu Jena, et al.
Cancer Research|September 13, 2014
Effective cancer vaccine platform based on attenuated salmonella and a type III secretion systemXin Xu, Wael A H Hegazy, Linjie Guo, et al.
Cancer Immunology Research|March 20, 2026
Co-expression of IL15 promotes effector differentiation and sustained proliferative capacity in ALPPL2-specific human CAR T cellsDavid Cunningham, Junquan Liu, Inci Cevher Zeytin, et al.
Journal for Immunotherapy of Cancer|March 7, 2023
Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-α triggers tumorigenic inflammation in neuroblastomaJulie A Tomolonis, Xin Xu, Kshiti H Dholakia, et al.
Cancer Immunology Research|January 19, 2020
Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular CarcinomaSai Arun Batra, Purva Rathi, Linjie Guo, et al.
Cancer Research|May 21, 2013
G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenicDanielle M Hsu, Saurabh Agarwal, Ashley Benham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2019
NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced <i>In Vivo</i> Persistence and Antitumor Activity against NeuroblastomaXin Xu, Wei Huang, Andras Heczey, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2018
IL-21 Selectively Protects CD62L<sup>+</sup> NKT Cells and Enhances Their Effector Functions for Adoptive ImmunotherapyHo Ngai, Gengwen Tian, Amy N Courtney, et al.
The Journal of Clinical Investigation|May 9, 2012
IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activityDaofeng Liu, Liping Song, Jie Wei, et al.
Blood|July 23, 2014
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapyAndras Heczey, Daofeng Liu, Gengwen Tian, et al.
The Journal of Clinical Investigation|May 17, 2016
CD62L+ NKT cells have prolonged persistence and antitumor activity in vivoGengwen Tian, Amy N Courtney, Bipulendu Jena, et al.
Cancer Research|September 13, 2014
Effective cancer vaccine platform based on attenuated salmonella and a type III secretion systemXin Xu, Wael A H Hegazy, Linjie Guo, et al.
Cancer Immunology Research|March 20, 2026
Co-expression of IL15 promotes effector differentiation and sustained proliferative capacity in ALPPL2-specific human CAR T cellsDavid Cunningham, Junquan Liu, Inci Cevher Zeytin, et al.
Journal for Immunotherapy of Cancer|March 7, 2023
Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-α triggers tumorigenic inflammation in neuroblastomaJulie A Tomolonis, Xin Xu, Kshiti H Dholakia, et al.
Cancer Immunology Research|January 19, 2020
Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular CarcinomaSai Arun Batra, Purva Rathi, Linjie Guo, et al.
Cancer Research|May 21, 2013
G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenicDanielle M Hsu, Saurabh Agarwal, Ashley Benham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2019
NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced <i>In Vivo</i> Persistence and Antitumor Activity against NeuroblastomaXin Xu, Wei Huang, Andras Heczey, et al.
Pageof 4